Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients

Introduction: Chronic Spontaneous Urticaria (CSU) is frequently encountered in our day to day practice. Patients are often reluctant to take medicines for prolonged durations and seek interventions for rapid and prolonged remission. Autologous Whole Blood Therapy (AWBT) has been used with varied res...

Full description

Bibliographic Details
Main Authors: Manjunath V Marigeri, Radhakrishnan Subramaniyan, Manasa Shettisara Janney, Navya Donaparthi
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/17801/59655_CE[Ra1]_F(IS)_PF1(JY_KM_SS)_PFA(SS_KM_OM)__PN(KM).pdf
_version_ 1797838562122530816
author Manjunath V Marigeri
Radhakrishnan Subramaniyan
Manasa Shettisara Janney
Navya Donaparthi
author_facet Manjunath V Marigeri
Radhakrishnan Subramaniyan
Manasa Shettisara Janney
Navya Donaparthi
author_sort Manjunath V Marigeri
collection DOAJ
description Introduction: Chronic Spontaneous Urticaria (CSU) is frequently encountered in our day to day practice. Patients are often reluctant to take medicines for prolonged durations and seek interventions for rapid and prolonged remission. Autologous Whole Blood Therapy (AWBT) has been used with varied results in CSU and Autologous Serum Skin Test (ASST) reactivity has shown to influence the therapeutic response in some studies. Aim: To compare the efficacy of AWBT in ASST positive versus negative CSU. Materials and Methods: The present prospective, interventional, parallel group study was conducted in the Department of Dermatology, Command Hospital Air Force (tertiary care centre), Bangalore, India, from January 2014 to December 2015. Eight weekly injections of AWB (5 mL) were administered to 30 ASST positive and 30 age and sex matched ASST negative patients of CSU and followed-up for four weeks. Modified Urticaria Severity Score (MUSS) was recorded at baseline, 4th, 8th and 12th weeks to assess objective response to AWBT. Subjective response was documented as poor, satisfactory, good and excellent based on patient’s feedback at the end of 12 weeks. Independent two-sample t-test, Chi-square (χ2) test and cross tabulations were used to analyse the data through Statistical Package for the Social Sciences (SPSS) software version 21.0. A p-value of <0.05 was considered statistically significant. Results: A total of 102 consenting patients were subjected to ASST, out of which 38 patients were ASST positive. After excluding those who were lost to follow-up, data from 30 ASST positive patients and corresponding age and sex matched ASST negative controls were analysed. Baseline MUSS of ASST positive group was significantly higher, indicating more severe nature of CSU. With AWBT, improvement in MUSS of ASST positive group (68.49±10.32%) was significantly higher than the ASST negative group (p-value <0.001) and ASST positive group required significantly lesser doses of rescue antihistamines (p-value <0.001) at the end of 12 weeks. Subjective response to AWBT was either good or excellent in both groups. Conclusion: Although AWBT resulted in significant reduction of MUSS in ASST positive patients, it benefited patients in both groups irrespective of their ASST reactivity status. AWBT can be used as an effective adjuvant in the treatment of CSU.
first_indexed 2024-04-09T15:43:57Z
format Article
id doaj.art-3091d412773f4d4db31c0173ced94f94
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-09T15:43:57Z
publishDate 2023-04-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-3091d412773f4d4db31c0173ced94f942023-04-27T05:29:11ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2023-04-01174WC09WC1310.7860/JCDR/2023/59655.17801Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative PatientsManjunath V Marigeri0Radhakrishnan Subramaniyan1Manasa Shettisara Janney2Navya Donaparthi3Specialist Medical Officer, Department of Dermatology, Haveri Institute of Medical Sciences, Haveri, Karnataka, India.Professor, Department of Dermatology, Army College of Medical Sciences, Delhi, India.Assistant Professor, Department of Dermatology, Command Hospital Air Force Bangalore, Bangalore, Karnataka, India.Associate Professor, Department of Dermatology, Command Hospital Air Force Bangalore, Bangalore, Karnataka, IndiaIntroduction: Chronic Spontaneous Urticaria (CSU) is frequently encountered in our day to day practice. Patients are often reluctant to take medicines for prolonged durations and seek interventions for rapid and prolonged remission. Autologous Whole Blood Therapy (AWBT) has been used with varied results in CSU and Autologous Serum Skin Test (ASST) reactivity has shown to influence the therapeutic response in some studies. Aim: To compare the efficacy of AWBT in ASST positive versus negative CSU. Materials and Methods: The present prospective, interventional, parallel group study was conducted in the Department of Dermatology, Command Hospital Air Force (tertiary care centre), Bangalore, India, from January 2014 to December 2015. Eight weekly injections of AWB (5 mL) were administered to 30 ASST positive and 30 age and sex matched ASST negative patients of CSU and followed-up for four weeks. Modified Urticaria Severity Score (MUSS) was recorded at baseline, 4th, 8th and 12th weeks to assess objective response to AWBT. Subjective response was documented as poor, satisfactory, good and excellent based on patient’s feedback at the end of 12 weeks. Independent two-sample t-test, Chi-square (χ2) test and cross tabulations were used to analyse the data through Statistical Package for the Social Sciences (SPSS) software version 21.0. A p-value of <0.05 was considered statistically significant. Results: A total of 102 consenting patients were subjected to ASST, out of which 38 patients were ASST positive. After excluding those who were lost to follow-up, data from 30 ASST positive patients and corresponding age and sex matched ASST negative controls were analysed. Baseline MUSS of ASST positive group was significantly higher, indicating more severe nature of CSU. With AWBT, improvement in MUSS of ASST positive group (68.49±10.32%) was significantly higher than the ASST negative group (p-value <0.001) and ASST positive group required significantly lesser doses of rescue antihistamines (p-value <0.001) at the end of 12 weeks. Subjective response to AWBT was either good or excellent in both groups. Conclusion: Although AWBT resulted in significant reduction of MUSS in ASST positive patients, it benefited patients in both groups irrespective of their ASST reactivity status. AWBT can be used as an effective adjuvant in the treatment of CSU.https://www.jcdr.net/articles/PDF/17801/59655_CE[Ra1]_F(IS)_PF1(JY_KM_SS)_PFA(SS_KM_OM)__PN(KM).pdfantihistamineserythemamodified urticaria severity scorepruritus
spellingShingle Manjunath V Marigeri
Radhakrishnan Subramaniyan
Manasa Shettisara Janney
Navya Donaparthi
Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
Journal of Clinical and Diagnostic Research
antihistamines
erythema
modified urticaria severity score
pruritus
title Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
title_full Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
title_fullStr Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
title_full_unstemmed Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
title_short Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
title_sort autologous whole blood therapy in chronic spontaneous urticaria a comparative study between autologous serum skin test positive and negative patients
topic antihistamines
erythema
modified urticaria severity score
pruritus
url https://www.jcdr.net/articles/PDF/17801/59655_CE[Ra1]_F(IS)_PF1(JY_KM_SS)_PFA(SS_KM_OM)__PN(KM).pdf
work_keys_str_mv AT manjunathvmarigeri autologouswholebloodtherapyinchronicspontaneousurticariaacomparativestudybetweenautologousserumskintestpositiveandnegativepatients
AT radhakrishnansubramaniyan autologouswholebloodtherapyinchronicspontaneousurticariaacomparativestudybetweenautologousserumskintestpositiveandnegativepatients
AT manasashettisarajanney autologouswholebloodtherapyinchronicspontaneousurticariaacomparativestudybetweenautologousserumskintestpositiveandnegativepatients
AT navyadonaparthi autologouswholebloodtherapyinchronicspontaneousurticariaacomparativestudybetweenautologousserumskintestpositiveandnegativepatients